Abstract:
The present invention discloses a new anti-tumor medicament comprising a mutant of endostatin. The mutant comprises a mutation in the ATP-binding site of endostatin and has a decreased ATPase activity and an increased anti-angiogenesis activity.
Abstract:
The present invention relates to a new use of a known medicament. Specifically, the invention relates to methods and compositions for enhancing the therapeutic efficacy of a therapeutic agent by increasing the uptake of the therapeutic agent by target cells, and in particular relates to a pharmaceutical composition comprising a regulating agent of lipid raft/caveolae-dependent endocytic pathway and some therapeutic agents, such as anti-tumor agents. The invention also relates to a method for screening a regulating agent of lipid raft/caveolae-dependent endocytic pathway capable of enhancing the therapeutic efficacy of anti-tumor agents.
Abstract:
The present invention relates to a new use of a known medicament. Specifically, the invention relates to methods and compositions for enhancing the therapeutic efficacy of a therapeutic agent by increasing the uptake of the therapeutic agent by target cells, and in particular relates to a pharmaceutical composition comprising a regulating agent of lipid raft/caveolae-dependent endocytic pathway and some therapeutic agents, such as anti-tumor agents. The invention also relates to a method for screening a regulating agent of lipid raft/caveolae-dependent endocytic pathway capable of enhancing the therapeutic efficacy of anti-tumor agents.
Abstract:
The present invention relates to the diagnosis and treatment of cancer, and specifically to a method of diagnosing the presence or metastasis of cancer by detecting plasma Hsp90α having the amino acid sequence of SEQ ID No. 1 as a tumor marker. In addition, the present invention also relates to a method for the treatment of cancer and metastasis.
Abstract translation:本发明涉及癌症的诊断和治疗,具体涉及通过检测具有SEQ ID No.1的氨基酸序列的血浆Hsp90α作为肿瘤标记物来诊断癌症存在或转移的方法。 此外,本发明还涉及治疗癌症和转移的方法。
Abstract:
The present invention relates to a method of identifying cancer subjects, in particular human patients, who are suitable for anti-lymphangiogenesis therapy to prevent tumor growth and tumor metastasis. The present invention also relates to a new approach, which uses nucleolin as a bait to search and screen for lymphangiogenesis inhibitors or cancer suppressors, which function in a manner that is analogous to endostatin. The invention is based upon the discovery that nucleolin is specifically expressed on lymphangiogenic vessels and functions as a specific receptor for endostatin, and thus is involved in the signal transduction pathway of endostatin as an anti-lymphangiogenesis inhibitor. The present invention also discloses that cell surface nucleolin on lymphatic endothelial cells is a biomarker for lymphangiogenic vessels, which could be used for the prediction of tumor metastasis.
Abstract:
An approach is provided for selecting a network server. An apparatus comprising at least one processor, and at least one memory including computer program code, the at least one memory and the computer program code configured to, with the at least one processor, cause, at least in part, the apparatus to load from one or more network servers configuration information of one or more network servers used by a service provider network. The apparatus is also caused to select a network server in the service provider network based at least in part on at least one of network server latency and the network server load. The apparatus is further caused to set the network server as default network server used for at least one of current and future session on one or more user equipment.
Abstract:
An approach is provided for building a scalable service platform by initiating transmission of encrypted data from a public network cache. An access control server platform determines a first authorization key for a user and a second authorization key for a resource, and then encrypts the resource with the second authorization key, and encrypts the second authorization key with the first authorization key. The access control server platform initiates distribution of the encrypted second authorization key with the encrypted resource over a network. The access control server platform further initiates caching the encrypted second authorization key with the encrypted resource that meets a predefined threshold value (e.g., a data size, an access frequency, a modification frequency, or an auditing requirement) in a cache in the network, and initiates transmission of the cached and encrypted second authorization key with the cached and encrypted resource from the cache to at least one authorized entity.
Abstract:
The present invention discloses an anti-tumor conjugate and pharmaceutical composition or kits comprising the conjugate, as well as a method of producing the anti-tumor conjugate. The anti-tumor conjugate of the present invention is metabolically stable in vivo, and is ultimately available for the treatment of tumors and production of anti-tumor medicaments.
Abstract:
A method, a device and a system for combination of resource admission control are provided. The system includes the policy determination combination device and multiple bearer and transmission devices. The combination device combines functions and interfaces of two or multiple kinds of arbitrary policy determination devices in systems of different standards, and has multiple interfaces to be connected with the bearer and transmission devices, and selects the corresponding interface working protocol according to the type of bearer and transmission device. Multiple bearer and transmission devices are connected with the policy determination combination device by different interfaces. By setting policy determination combination device, the combination of policy determination devices is realized with a few changes to the current network. When there are multiple types of bearer and transmission devices in a management domain, the number of the policy determination devices can be efficiently reduced, and the cost of setting up the network and maintenance can be reduced. Also, it is propitious to collaborate and combine different standards and to improve speed of industrialization.
Abstract:
A method for pushing messages includes: categorizing a first information according to a first category set, creating a first mapping relation between the first information and a category in the first category set; categorizing a second information sent by a message source according to a second category set, and creating a second mapping relation between the message source that sends the second information and a category in the second category set; sorting out each category in the second category set that matches the corresponding category in the first category set which is in the first mapping relation with the first information according to the relation between the first category in the first category set and the second category in the second category set, and determining the corresponding message source according to the second mapping relation; and pushing the first information to the determined corresponding message source.